Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis

OBJECTIVES: Previously we demonstrated the benefit of isavuconazole in treating murine mucormycosis due to Rhizopus. We wanted to determine the efficacy of isavuconazole in treating murine mucormycosis caused by Mucor, the second most common cause of the disease. Furthermore, because we previously d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Gebremariam, Teclegiorgis, Wiederhold, Nathan P., Alqarihi, Abdullah, Uppuluri, Priya, Azie, Nkechi, Edwards, John E., Ibrahim, Ashraf S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6289498/
https://ncbi.nlm.nih.gov/pubmed/27798213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw433
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados